23.11.2016 14:50:53
|
DGAP-DD: Epigenomics AG
DGAP-DD: Epigenomics AG english
23.11.2016 / 14:49 The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name
Title: Dr. First name: Helge Last name(s): Lubenow
2. Reason for the notification
a) Position / status
Position: Member of the administrative or supervisory body
b) Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
Epigenomics AG
b) LEI
549300X1C4U862NDLN97
4. Details of the transaction(s)
a) Description of the financial instrument, type of instrument, identification code
Type: Share ISIN: DE000A11QW50
b) Nature of the transaction
Acquisition
c) Price(s) and volume(s)
Price(s) Volume(s) 4.748 EUR 3122.48 EUR 4.785 EUR 7727.03 EUR 4.79 EUR 6377.03 EUR 4.83 EUR 5055.12 EUR 4.70 EUR 1703.65 EUR
d) Aggregated information
Price Aggregated volume 4.797 EUR 23985.31 EUR
e) Date of the transaction
2016-11-23; UTC+1
f) Place of the transaction
Name: XETRA MIC: XETR
---------------------------------------------------------------------------
23.11.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English Company: Epigenomics AG Geneststraße 5 10829 Berlin Germany Internet: www.epigenomics.com End of News DGAP News Service ---------------------------------------------------------------------------
30885 23.11.2016
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
23.11.2016 / 14:49 The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name
Title: Dr. First name: Helge Last name(s): Lubenow
2. Reason for the notification
a) Position / status
Position: Member of the administrative or supervisory body
b) Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
Epigenomics AG
b) LEI
549300X1C4U862NDLN97
4. Details of the transaction(s)
a) Description of the financial instrument, type of instrument, identification code
Type: Share ISIN: DE000A11QW50
b) Nature of the transaction
Acquisition
c) Price(s) and volume(s)
Price(s) Volume(s) 4.748 EUR 3122.48 EUR 4.785 EUR 7727.03 EUR 4.79 EUR 6377.03 EUR 4.83 EUR 5055.12 EUR 4.70 EUR 1703.65 EUR
d) Aggregated information
Price Aggregated volume 4.797 EUR 23985.31 EUR
e) Date of the transaction
2016-11-23; UTC+1
f) Place of the transaction
Name: XETRA MIC: XETR
---------------------------------------------------------------------------
23.11.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English Company: Epigenomics AG Geneststraße 5 10829 Berlin Germany Internet: www.epigenomics.com End of News DGAP News Service ---------------------------------------------------------------------------
30885 23.11.2016
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Epigenomics AGmehr Nachrichten
Keine Nachrichten verfügbar. |